{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:59:49Z","timestamp":1792112389549,"version":"4.4.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical.theclinics.com","mdconsult.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.mcna.2014.06.012","type":"journal-article","created":{"date-parts":[[2014,7,12]],"date-time":"2014-07-12T12:00:32Z","timestamp":1405166432000},"page":"1193-1208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Medical Conditions with Neuropsychiatric Manifestations"],"prefix":"10.1016","volume":"98","author":[{"given":"Margaret L.","family":"Isaac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mcna.2014.06.012_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1212\/WNL.39.1.119","article-title":"Human immunodeficiency virus (HIV) infection and the nervous system: report from the American Academy of Neurology AIDS Task Force","volume":"39","author":"Janssen","year":"1989","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mcna.2014.06.012_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0924-9338(97)86374-2","article-title":"Neuropsychiatric aspects of HIV infection: a liaison psychiatry study","volume":"12","author":"Grassi","year":"1997","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.mcna.2014.06.012_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/1471-2334-11-356","article-title":"The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?","volume":"11","author":"Gissl\u00e9n","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2014.06.012_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J\u00a0Neurovirol"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.0b013e31827f0776","article-title":"Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons","volume":"80","author":"Crum-Cianflone","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mcna.2014.06.012_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/WNL.41.6.778","article-title":"Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS Task Force","volume":"41","year":"1991","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mcna.2014.06.012_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0272-7358(97)00021-4","article-title":"Severe mental illness and HIV-related medical and neuropsychiatric sequelae","volume":"17","author":"McDaniel","year":"1997","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"10.1016\/j.mcna.2014.06.012_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.54.3.743","article-title":"AIDS- and non-AIDS-related PML association with distinct p53 polymorphism","volume":"54","author":"Power","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.mcna.2014.06.012_bib10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/13550280701469178","article-title":"Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient","volume":"13","author":"Bernal-Cano","year":"2007","journal-title":"J\u00a0Neurovirol"},{"issue":"1","key":"10.1016\/j.mcna.2014.06.012_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/595299","article-title":"Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study","volume":"199","author":"Engsig","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"19","key":"10.1016\/j.mcna.2014.06.012_bib12","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM199805073381903","article-title":"Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team","volume":"338","author":"Hall","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"RR\u20134","key":"10.1016\/j.mcna.2014.06.012_bib13","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.mcna.2014.06.012_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1468-1331.2008.02337.x","article-title":"Impairment of short-term memory and Korsakoff syndrome are common in AIDS patients with cytomegalovirus encephalitis","volume":"16","author":"Pirskanen-Matell","year":"2009","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.mcna.2014.06.012_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/infdis\/172.2.527","article-title":"Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system","volume":"172","author":"Arribas","year":"1995","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.mcna.2014.06.012_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF02471907","article-title":"Relevance of clinical and laboratory findings in the diagnosis of cytomegalovirus encephalitis in patients with AIDS","volume":"16","author":"Mussini","year":"1997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.mcna.2014.06.012_bib17","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archinte.158.9.957","article-title":"Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA","volume":"158","author":"Whitley","year":"1998","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2014.06.012_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00002030-200003310-00007","article-title":"Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients","volume":"14","author":"Anduze-Faris","year":"2000","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.mcna.2014.06.012_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.46.2.444","article-title":"Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS","volume":"46","author":"Cohen","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2014.06.012_bib20","series-title":"Harrison's principles of internal medicine","author":"Fauci","year":"1998"},{"issue":"6","key":"10.1016\/j.mcna.2014.06.012_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1445-5994.2012.02814.x","article-title":"Clinical aspects of adult syphilis","volume":"42","author":"Read","year":"2012","journal-title":"Intern Med J"},{"issue":"5","key":"10.1016\/j.mcna.2014.06.012_bib22","first-page":"433","article-title":"Syphilis: a reemerging infection","volume":"86","author":"Mattei","year":"2012","journal-title":"Am Fam Physician"},{"issue":"RR\u201312","key":"10.1016\/j.mcna.2014.06.012_bib23","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/cid\/cit322","article-title":"Toward a better understanding of European Lyme neuroborreliosis","volume":"57","author":"Wormser","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2014.06.012_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1155\/1991\/902928","article-title":"Overview of the clinical manifestations of Borrelia burgdorferi infection","volume":"2","author":"Dattwyler","year":"1991","journal-title":"Can J Infect Dis"},{"issue":"Pt 4","key":"10.1016\/j.mcna.2014.06.012_bib26","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/brain\/113.4.1207","article-title":"Lyme neuroborreliosis. Peripheral nervous system manifestations","volume":"113","author":"Halperin","year":"1990","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.mcna.2014.06.012_bib27","first-page":"155","article-title":"CSF findings in Lyme meningitis","volume":"25","author":"Lakos","year":"1992","journal-title":"J\u00a0Infect"},{"issue":"9","key":"10.1016\/j.mcna.2014.06.012_bib28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mcna.2014.06.012_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/rheumatology\/41.6.605","article-title":"The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation","volume":"41","author":"Jennekens","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib30","first-page":"535","article-title":"The time course of acute psychiatric episodes in systemic lupus erythematosus","volume":"18","author":"Ward","year":"1991","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.mcna.2014.06.012_bib31","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.mcna.2014.06.012_bib32","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.mcna.2014.06.012_bib33","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.mcna.2014.06.012_bib35","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1191\/0961203304lu2024oa","article-title":"ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables","volume":"13","author":"Hanly","year":"2004","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.mcna.2014.06.012_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/s10165-009-0198-5","article-title":"Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers","volume":"19","author":"Efthimiou","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib37","doi-asserted-by":"crossref","first-page":"R366","DOI":"10.1186\/ar1198","article-title":"Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies","volume":"6","author":"Conti","year":"2004","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.mcna.2014.06.012_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/ard.53.5.304","article-title":"Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte\/neuronal 52 kd reactivity","volume":"53","author":"Denburg","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.mcna.2014.06.012_bib39","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archneur.60.8.1166","article-title":"Neurosarcoidosis","volume":"60","author":"Burns","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mcna.2014.06.012_bib40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/B978-0-7020-4086-3.00021-7","article-title":"Neurologic manifestations of sarcoidosis","volume":"119","author":"Krumholz","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10.1016\/j.mcna.2014.06.012_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.mcna.2014.06.012_bib42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MCP.0b013e32833c86df","article-title":"A\u00a0pragmatic approach to diagnosing and treating neurosarcoidosis in the 21st century","volume":"16","author":"Hoitsma","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"9323","key":"10.1016\/j.mcna.2014.06.012_bib43","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(02)08912-2","article-title":"Small fibre neuropathy in sarcoidosis","volume":"359","author":"Hoitsma","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mcna.2014.06.012_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MD.0b013e31815585aa","article-title":"Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature","volume":"86","author":"Bihan","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.mcna.2014.06.012_bib45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0090-3019(81)90144-0","article-title":"Neurosarcoidosis: a review of the rarer manifestations","volume":"15","author":"Cahill","year":"1981","journal-title":"Surg Neurol"},{"issue":"3","key":"10.1016\/j.mcna.2014.06.012_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000314225","article-title":"Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment","volume":"80","author":"Elfferich","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.mcna.2014.06.012_bib47","first-page":"413","article-title":"The psychiatric manifestations of endocrine disease","volume":"29","author":"Leigh","year":"1984","journal-title":"Adv Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2014.06.012_bib48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1017\/S1355617705050642","article-title":"Anxiety and depression, attention, and executive functions in hypothyroidism","volume":"11","author":"Constant","year":"2005","journal-title":"J\u00a0Int Neuropsychol Soc"},{"issue":"2","key":"10.1016\/j.mcna.2014.06.012_bib49","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archneur.63.2.218","article-title":"Incidence and causes of nondegenerative nonvascular dementia: a population-based study","volume":"63","author":"Knopman","year":"2006","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.mcna.2014.06.012_bib50","first-page":"333","article-title":"Reversibility of dementia in hypothyroidism","volume":"240","author":"Haupt","year":"1993","journal-title":"J\u00a0Neurol"},{"issue":"7","key":"10.1016\/j.mcna.2014.06.012_bib51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1212\/WNL.8.7.511","article-title":"Neurologic manifestations of myxedema","volume":"8","author":"Nickel","year":"1958","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mcna.2014.06.012_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1176\/jnp.8.2.181","article-title":"A\u00a0survey study of neuropsychiatric complaints in patients with Graves' disease","volume":"8","author":"Stern","year":"1996","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5694\/j.1326-5377.1996.tb94135.x","article-title":"Hyperthyroidism in elderly hospitalised patients. Clinical features and treatment outcomes","volume":"164","author":"Martin","year":"1996","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.mcna.2014.06.012_bib54","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jnnp.68.6.750","article-title":"Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study","volume":"68","author":"Duyff","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"9","key":"10.1016\/j.mcna.2014.06.012_bib55","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1089\/thy.2009.0276","article-title":"The prevalence of thyrotoxicosis-related seizures","volume":"20","author":"Song","year":"2010","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.mcna.2014.06.012_bib56","first-page":"76","article-title":"Thyrotoxic neuropathy- an under diagnosed condition","volume":"62","author":"Sahni","year":"2007","journal-title":"Med J Malaysia"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2014.06.012_bib57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000314317","article-title":"Neuropsychiatric disorders in Cushing's syndrome","volume":"92","author":"Pereira","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.mcna.2014.06.012_bib58","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2265.1996.8690878.x","article-title":"A\u00a0prospective study of psychiatric and psychological aspects of Cushing's syndrome","volume":"45","author":"Kelly","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.mcna.2014.06.012_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00006842-198102000-00002","article-title":"Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels","volume":"43","author":"Starkman","year":"1981","journal-title":"Psychosom Med"},{"issue":"7","key":"10.1016\/j.mcna.2014.06.012_bib60","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/qjmed\/89.7.543","article-title":"Psychiatric aspects of Cushing's syndrome","volume":"89","author":"Kelly","year":"1996","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.mcna.2014.06.012_bib61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ecl.2013.05.010","article-title":"Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration","volume":"42","author":"Starkman","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.mcna.2014.06.012_bib62","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ecl.2011.01.006","article-title":"Cushing's syndrome: all variants, detection, and treatment","volume":"40","author":"Sharma","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib63","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2265.2004.02118.x","article-title":"Long-term negative impact on quality of life in patients with successfully treated Cushing's disease","volume":"61","author":"Heald","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.mcna.2014.06.012_bib64","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0889-8529(18)30087-2","article-title":"Cushing's syndrome from the patient's perspective","volume":"23","author":"Gotch","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.mcna.2014.06.012_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(13)61684-0","article-title":"Adrenal insufficiency","author":"Charmandari","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mcna.2014.06.012_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00006842-197201000-00008","article-title":"Psychiatric disturbance in endocrinologic disease","volume":"34","author":"Smith","year":"1972","journal-title":"Psychosom Med"},{"issue":"10","key":"10.1016\/j.mcna.2014.06.012_bib67","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1210\/jc.2007-0685","article-title":"Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis","volume":"92","author":"Hahner","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mcna.2014.06.012_bib68","first-page":"1","article-title":"The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations","volume":"7","author":"Victor","year":"1971","journal-title":"Contemp Neurol Ser"},{"issue":"1","key":"10.1016\/j.mcna.2014.06.012_bib69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1176\/appi.neuropsych.11020052","article-title":"The neuropsychiatry of vitamin B12 deficiency in elderly patients","volume":"24","author":"Lachner","year":"2012","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.mcna.2014.06.012_bib70","series-title":"Cecil textbook of medicine","first-page":"1054","author":"Stabler","year":"2004"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib71","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00005792-199107000-00001","article-title":"Neurologic aspects of cobalamin deficiency","volume":"70","author":"Healton","year":"1991","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.mcna.2014.06.012_bib72","first-page":"174","article-title":"Neuropsychiatric manifestations and their outcomes in chronic hypocalcaemia","volume":"111","author":"Maiti","year":"2013","journal-title":"J\u00a0Indian Med Assoc"},{"key":"10.1016\/j.mcna.2014.06.012_bib73","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/B978-0-7020-4087-0.00056-5","article-title":"Porphyria and its neurologic manifestations","volume":"120","author":"Tracy","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"9","key":"10.1016\/j.mcna.2014.06.012_bib74","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jocn.2011.01.003","article-title":"The neurologic manifestations of the acute porphyrias","volume":"18","author":"Simon","year":"2011","journal-title":"J\u00a0Clin Neurosci"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib75","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp.62.4.319","article-title":"The little imitator\u2013porphyria: a neuropsychiatric disorder","volume":"62","author":"Crimlisk","year":"1997","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"4","key":"10.1016\/j.mcna.2014.06.012_bib76","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10545-013-9618-y","article-title":"The neuropsychiatry of inborn errors of metabolism","volume":"36","author":"Walterfang","year":"2013","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"6","key":"10.1016\/j.mcna.2014.06.012_bib77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias","volume":"142","author":"Anderson","year":"2005","journal-title":"Ann Intern Med"},{"issue":"23","key":"10.1016\/j.mcna.2014.06.012_bib78","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1182\/blood-2012-05-423186","article-title":"The porphyrias: advances in diagnosis and treatment","volume":"120","author":"Balwani","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mcna.2014.06.012_bib79","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199205000-00004","article-title":"Wilson disease","volume":"71","author":"Brewer","year":"1992","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.mcna.2014.06.012_bib80","first-page":"409","article-title":"The ophthalmologic manifestations of Wilson's disease","volume":"52","author":"Wiebers","year":"1977","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.mcna.2014.06.012_bib81","first-page":"538","article-title":"Recognition and treatment of neurologic Wilson's disease","volume":"32","author":"Lorincz","year":"2012","journal-title":"Semin Neurol"},{"issue":"3","key":"10.1016\/j.mcna.2014.06.012_bib82","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.seminoncol.2006.03.008","article-title":"Paraneoplastic syndromes affecting the nervous system","volume":"33","author":"Darnell","year":"2006","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.mcna.2014.06.012_bib83","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants: classification, diagnosis and treatment","volume":"13","author":"T\u00fcz\u00fcn","year":"2007","journal-title":"Neurologist"},{"issue":"9","key":"10.1016\/j.mcna.2014.06.012_bib84","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1176\/appi.ajp.2010.09101547","article-title":"Psychiatric manifestations of paraneoplastic disorders","volume":"167","author":"Kayser","year":"2010","journal-title":"Am J Psychiatry"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251400100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251400100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T15:10:04Z","timestamp":1565622604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571251400100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S002571251400100X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2014.06.012","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical Conditions with Neuropsychiatric Manifestations","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2014.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}